Nebnext multiplex oligos and nebnext ultratm II DNA and RNA library prep kits
Ended Awarded Last action
- Contract number
- 75N92B24F00003
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
National Insititue of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,590
Award facts
- Contract value 100% obligated
- $11,590.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
About this award
New England Biolabs, Inc. has been awarded a Blanket Purchase Agreement (BPA) call order valued at $11,590.40 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health. The award, issued on June 5, 2024, with a completion date of June 4, 2025, is for NEBNext Multiplex Oligos and NEBNext Ultra II DNA and RNA Library Prep Kits. This contract does not carry a set-aside designation and operates under a firm fixed price structure. The products will be performed at the vendor's facility in Ipswich, Massachusetts, and represent specialized reagents and kits essential for next-generation sequencing and genomic research applications.
This award is issued under New England Biolabs' larger single-award BPA with the NIH Office of Logistics and Acquisition Operations, valued at $10 million and effective through January 31, 2026. The company, a leading manufacturer of molecular biology products and research tools, has established itself as a primary supplier to NIH institutes for genomics, infectious disease research, and other biomedical investigations. NIAMS utilizes this BPA vehicle to efficiently procure critical molecular biology products needed for its research mission, with individual task orders typically ranging between $12,000 and $25,000. The library preparation kits and oligonucleotide products delivered under this call support foundational research activities across the institute's laboratories.
Quick answers
Who was awarded contract 75N92B24F00003?
75N92B24F00003 was awarded to New England Biolabs, Inc. by National Insititue of Arthritis and Musculoskeletal and Skin Diseases (National Institutes of Health) on June 5, 2024.
How much is contract 75N92B24F00003 worth?
The government has obligated $11,590 on 75N92B24F00003.
Is contract 75N92B24F00003 an order under another contract?
Yes. 75N92B24F00003 is a BPA call under 75N98024A00061, a blanket purchase agreement.
Was contract 75N92B24F00003 competed?
The extent of competition for 75N92B24F00003 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award